Stock Information

Hatay Pharmaceutical Joint Stock Company (HNX | Retail)

FINANCIAL RATIO »

Market Cap (VNDbn)

Outstanding shares (Shares)

BVS (VND)

EPS (VND)

P/E (Times)

P/B (Times)

EBIT (VNDbn)

EBITDA (VNDbn)

ROA (%)

ROE (%)

Debt/Total Assets

Gross Profit Margin (%)

Net Profit Margin (%)

Quick Ratio

Cash Ratio

Current Ratio

FINANCIAL DATA »

Peer Comparison

Ticker Price Change P/E P/B
DHT 34,550 +550 (+1.62) 36.01 2.74
Latest Update: 12:00 AM | 5/17/2024

Ownership structure

Major shareholder

Major Shareholder Rate %
Aska Pharmaceutical., Ltd 34.99%
Hatay Pharmaceutical Joint Stock Company 3.76%
Duong Huu Hieu 3.64%
Ha Tay Pharmaceutical And Healthcare Equipment Jsc 2.61%
Le Phuong Thao 2.44%

View more

Shareholder Documents

Document Name Date
Unaudited financial statements Q1 - 2024 26/04/2024
Audited financial statements Year 2023 01/03/2024
Unaudited financial statements Q4 - 2023 18/01/2024
Unaudited financial statements Q3 - 2023 17/10/2023
Unaudited financial statements Q2 - 2023 19/07/2023

Xem thêm